Chiara Brignole Selected Research

Chiara Brignole Research Topics

Disease

37	Neoplasms (Cancer) 02/2024 - 10/2003
35	Neuroblastoma 01/2023 - 01/2003
5	Melanoma (Melanoma, Malignant) 08/2021 - 05/2003
4	Carcinogenesis 03/2022 - 02/2005
3	Lung Neoplasms (Lung Cancer) 11/2021 - 11/2008
2	Neoplasm Metastasis (Metastasis) 05/2021 - 10/2003
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021
1	Liver Diseases (Liver Disease) 01/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Cicatrix (Scar) 01/2016
1	Necrosis 09/2013
1	Ovarian Neoplasms (Ovarian Cancer) 11/2008
1	Carcinoma (Carcinomatosis) 02/2005
1	Neuroectodermal Tumors (Neuroectodermal Tumor) 12/2004
1	Experimental Melanoma 10/2003

Drug/Important Bio-Agent (IBA)

18	Liposomes (Liposome)IBA 08/2021 - 10/2003
11	Peptides (Polypeptides)IBA 06/2021 - 11/2003
9	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2021 - 01/2003
6	LigandsIBA 11/2015 - 10/2006
6	CD13 Antigens (Alanine Aminopeptidase)IBA 08/2015 - 11/2003
5	RetinoidsIBA 08/2021 - 05/2003
5	FenretinideIBA 08/2021 - 05/2003
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2013 - 12/2004
4	Monoclonal AntibodiesIBA 01/2013 - 10/2003
4	AntigensIBA 07/2010 - 08/2004
3	MicroRNAs (MicroRNA)IBA 10/2022 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 06/2021 - 10/2003
3	Anaplastic Lymphoma KinaseIBA 10/2015 - 06/2011
3	Bortezomib (Velcade)FDA Link 08/2015 - 08/2006
3	AntibodiesIBA 09/2013 - 10/2005
3	Matrix Metalloproteinases (MMPs)IBA 09/2013 - 12/2004
3	Antisense OligonucleotidesIBA 10/2005 - 07/2003
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2023 - 06/2021
2	NucleolinIBA 11/2022 - 06/2021
2	Antineoplastic Agents (Antineoplastics)IBA 03/2022 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 11/2015
2	LipidsIBA 01/2016 - 01/2009
2	SuspensionsIBA 11/2015 - 08/2006
2	Glutamyl Aminopeptidase (Aspartyl Aminopeptidase)IBA 01/2013 - 07/2010
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2011 - 06/2011
2	Small Interfering RNA (siRNA)IBA 12/2011 - 06/2011
2	Therapeutic UsesIBA 02/2009 - 07/2007
2	liposomal doxorubicin (Doxil)FDA Link 11/2008 - 11/2003
2	OligodeoxyribonucleotidesIBA 12/2004 - 10/2003
2	Immunoglobulin Fab FragmentsIBA 07/2003 - 01/2003
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	DuocarmycinsIBA 01/2023
1	Temozolomide (Temodar)FDA LinkGeneric 01/2023
1	Tetrazolium SaltsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	CSK Tyrosine-Protein KinaseIBA 03/2022
1	pyrimidineIBA 03/2022
1	RNA (Ribonucleic Acid)IBA 03/2022
1	Lipid NanoparticlesIBA 11/2021
1	Nanoparticle Drug Delivery SystemIBA 08/2021
1	Peptide TIBA 06/2021
1	Surface Antigens (Surface Antigen)IBA 05/2021
1	Neuropilin-1IBA 11/2018
1	Coloring Agents (Dyes)IBA 11/2018
1	Evans Blue (Blue, Evans)FDA Link 11/2018
1	Immunoglobulin FragmentsIBA 01/2016
1	ensartinibIBA 10/2015
1	CrizotinibIBA 10/2015
1	Tyrosine Kinase InhibitorsIBA 10/2015
1	OligonucleotidesIBA 01/2013
1	Toll-Like Receptor 9IBA 12/2010
1	Proteasome InhibitorsIBA 02/2009
1	Protein Isoforms (Isoforms)IBA 11/2008
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2007
1	Sirolimus (Rapamycin)FDA Link 07/2007
1	Vinblastine (Vinblastine Sulfate)FDA Link 07/2007
1	Drug CarriersIBA 01/2007
1	CaspasesIBA 08/2006
1	ATP dependent 26S protease (26S proteasome)IBA 08/2006
1	Conditioned Culture MediaIBA 08/2006
1	DNA (Deoxyribonucleic Acid)IBA 02/2005
1	NF-kappa B (NF-kB)IBA 02/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2004
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2004
1	Proto-Oncogene Proteins c-mybIBA 12/2004
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 12/2004
1	Caspase 8 (Caspase-8)IBA 12/2004
1	EpitopesIBA 11/2003
1	NGR peptideIBA 11/2003
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 11/2003

Therapy/Procedure

22	Therapeutics 01/2023 - 05/2003
5	Drug Therapy (Chemotherapy) 11/2018 - 11/2003
3	Precision Medicine 02/2024 - 09/2022
2	Investigational Therapies (Experimental Therapy) 01/2019 - 07/2003
1	Molecular Targeted Therapy 02/2024
1	Ligation 01/2016
1	Metronomic Administration 11/2003